胆管癌及其分子改变

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
林海元
文章摘要
胆管癌(CCA)是肝胆系统的一种高致死性腺癌,可分为肝内、肝门周围和远端。每种解剖亚型都有不同的遗传畸变、临床表现和治疗方法。组织学上,传统的肝门周围/远端胆管癌是产生粘蛋白的腺癌或乳头状肿瘤;肝内胆管癌更具异质性,可以根据显示的胆管的水平或大小进行细分。胆管癌通过多步癌发生发展,并先出现发育异常和原位病变。本文讨论了胆管癌及其分子改变。
文章关键词
胆管癌;解剖;分子改变
参考文献
[1] Brindley PJ,Bachini M,Ilyas SI,Khan SA,Loukas A,Sirica AE,Teh BT,Wongkham S,Gores GJ.Cholangiocarcinoma.Nat Rev Dis Primers.2021 Sep 9;7(1):65. [2] Jhaveri KS&Hosseini-Nik H MRI of cholangiocarcinoma.J.Magn.Reson.Imaging 42,1165–1179(2015). [3] Saluja SS,Sharma R,Pal S,Sahni P&Chattopadhyay TK Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations:a prospective study.HPB 9,373–382(2007). [4] Trikudanathan G,Navaneethan U,Njei B,Vargo JJ&Parsi MA Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis:a systematic review and meta-analysis.Gastrointest.Endosc 79,783–789(2014). [5] Barr Fritcher EG et al.An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples.Gastroenterology 149,1813–1824.e1(2015). [6] Bergquist A,von Seth E.Epidemiology of cholangiocarcinoma.Best Pract Res Clin Gastroenterol.2015 Apr;29(2):221-32. [7] Kendall T,Verheij J,Gaudio E,Evert M,Guido M,Goeppert B,Carpino G.Anatomical,histomorphological and molecular classification of cholangiocarcinoma.Liver Int.2019 May;39 Suppl 1:7-18. [8] Vannas MJ,Boyd S,FärkkiläMA,Arola J,Isoniemi H.Value of brush cytology for optimal timing of liver transplantation in pri‐mary sclerosing cholangitis.Liver Int.2017;37:735‐742. [9] Nakamura H,Arai Y,Totoki Y,et al.Genomic spectra of biliary tract cancer.Nat Genet.2015;47:1003‐1010. [10] Borger DR,Tanabe KK,Fan KC,et al.Frequent mutation of isoc‐itrate dehydrogenase(IDH)1 and IDH2 in cholangiocarcinoma identified through broad‐based tumor genotyping.Oncologist.2012;17:72‐79. [11] Kipp BR,Voss JS,Kerr SE,et al.Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.Hum Pathol.2012;43:1552‐1558. [12] Kongpetch S,Jusakul A,Ong CK,Lim WK,Rozen SG,Tan P,Teh BT.Pathogenesis of cholangiocarcinoma:From genetics to signalling pathways.Best Pract Res Clin Gastroenterol.2015 Apr;29(2):233-44.
Full Text:
DOI